[Studies on antamanide. XIV. Mode of action].
D000818:Animals; D000992:Antitoxins / Q000008:administration & dosage / Q000494:pharmacology*; D001345:Autoradiography; D002247:Carbon Isotopes; D002463:Cell Membrane Permeability / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008099:Liver / Q000032:analysis / Q000187:drug effects* / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009183:Mycotoxins / Q000008:administration & dosage / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D010477:Perfusion; D051381:Rats; D011919:Rats, Inbred Strains; D011955:Receptors, Drug
D000992:Antitoxins; D002247:Carbon Isotopes; D009183:Mycotoxins; D010455:Peptides; D011955:Receptors, Drug
Uber Antamanid. XIV. Zur Wirkungsweise des Antamanids.